Novartis in Ireland

Company Overview

• Novartis Ireland Limited is the Irish affiliate of Swiss-based Novartis AG – one of the largest and most widely respected pharmaceutical companies in the world.
• Reflecting our commitment to innovation, 18% of pharma net sales is invested back into research and development, focusing on the areas of greatest patient need and scientific promise¹.

Novartis is one of Ireland’s leading employers in the healthcare industry. One of the first pharmaceutical companies to locate in Ireland in the 1950’s, Novartis has strong history of  investing in Ireland over the last sixty years.

Novartis employs approximately 1,600 people across 3 locations in Cork and Dublin. Novartis manufacturing and development is based in Ringaskiddy, Co Cork.  Alcon, located on the Model Farm road is the leading manufacturer of technologies used to treat cataracts. In March 2013 Novartis announced the establishment of a Global Business Services Center in Elm Park. Novartis Pharmaceuticals is also based in Elm Park. 

The Irish Pharmaceutical industry currently generates over 50 percent of the country’s exports contributing to making Ireland the largest net exporter of medicines in the EU. 9 of the top 10 pharma companies in the world are located in Ireland.  The industry directly employs over 24,500 people, over half of which are third level graduates.

Novartis Commercial Operations:

Our mission is to develop and successfully make available to patients innovative products to prevent and treat disease and to enhance quality of life, while partnering with stakeholders to develop sustainable business solutions. Novartis Pharma has six health care businesses: Respiratory, Neuroscience, Cardiology, Dermatology, Ophthalmology and Oncology. Novartis has been recognised as having the best pipeline in the world, with over 140 products in clinical development. Novartis Pharma is committed to R&D, we are the number one pharma investor in clinical trials in Ireland. We are proud to say, in 2016, circa 30 clinical trials were conducted in Ireland, in partnership with approximately 20 Irish hospitals, involving over 900 Irish patients. We supply prescription medicines across diverse therapeutic areas such as neurology, oncology, respiratory, ophthalmology, dermatology and cardiology. For more information on our products, please go to www.medicines.ie

Novartis Business Services Center:

The Novartis Global Service Center (NGSC), Dublin, was set up in 2013 and is located in a state-of-the-art facility on the Merrion Road in Ballsbridge. The center, one of five around the world, delivers a broad variety of services to the Novartis divisions and organisations worldwide. Services offered by the Dublin team include scientific and commercial services, IT, HR operations and procurement.

The operation is continuing to grow rapidly and has a number of exciting vacancies for experienced high-cailbre candidates who are interested in working as part of an international team delivering services globally. For more details, please see the careers page

Novartis Ringaskiddy:

Novartis Ringaskiddy is home to both the manufacturing site, Novartis Ringaskiddy Limited (NRL) and to Novartis International Pharmaceutical Ltd, Branch Ireland (NIPBI) which is comprised of the International Services Laboratory, the External Supply Organisation, Supply Chain and administrative functions.

Novartis Ringaskiddy manufactures active pharmaceutical ingredients for a range of oncology, respiratory, cardiovascular, dermatology, central nervous system and transplantation medicines. Employing approximately 600 people across the Ringaskiddy campus both NRL and NIPBI are an important part of the Novartis global network.

Alcon:

Cork is home to Alcon’s European manufacturing center for AcrySof® intraocular lenses.  Over 350 associates work at the Alcon Cork facility. In 2012 Novartis fully acquired Alcon, making Novartis the world’s number one eye care company in the world.  Alcon’s mission is to provide innovative products that enhance quality of life by helping people see better.

References:

1. Novartis AG Company report, 2015, page 44